Molecular imaging as a tool for translating breast cancer science

por Mankoff, David A
Publicado 2008

PET/MRI for Primary Breast Cancer: A Match Made Better by PET Quantification?

por Mankoff, David A., Surti, Suleman
Publicado en Radiol Imaging Cancer (2021)

Advances in molecular imaging for breast cancer detection and characterization

por Specht, Jennifer M, Mankoff, David A
Publicado 2012

The contribution of physics to Nuclear Medicine: physicians’ perspective on future directions

por Mankoff, David A, Pryma, Daniel A
Publicado en EJNMMI Phys (2014)

Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers

por Pantel, Austin R., Mankoff, David A.
Publicado en Cancer Lett (2016)

Characterizing Tumors Using Metabolic Imaging: PET Imaging of Cellular Proliferation and Steroid Receptors

por Mankoff, David A, Dehdashti, Farrokh, Shields, Anthony F
Publicado 2000

Predicting Breast Cancer Endocrine Responsiveness Using Molecular Imaging

por Currin, Erin, Linden, Hannah M., Mankoff, David A.
Publicado 2011

Disease Restaging and Diagnosis of Recurrent and Metastatic Disease Following Primary Therapy with FDG-PET Imaging

por Eubank, William B., Lee, Jean H., Mankoff, David A.
Publicado 2009

Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials

por Doot, Robert K., McDonald, Elizabeth S., Mankoff, David A.
Publicado 2014

The Value of Establishing the Quantitative Accuracy of PET/CT Imaging

por Kinahan, Paul E., Mankoff, David A., Linden, Hannah M.
Publicado en J Nucl Med (2015)

Letter to the Editor Response to CCR-16-0362R: Authors’ reply

por Kurland, Brenda F., Linden, Hannah M., Mankoff, David A.
Publicado en Clin Cancer Res (2017)

A PET Glutamate Analog to Measure Cancer Cell Redox State and Oxidative Stress: Promise and Paradox

por Lee, Hsiaoju S., Pantel, Austin R., Zhou, Rong, Mankoff, David A.
Publicado en Cancer Res (2019)

Quantitation of Multiple Injection Dynamic PET Scans: An Investigation of the Benefits of Pooling Data from Separate Scans when Mapping Kinetics

por Gu, Fengyun, O’Sullivan, Finbarr, Muzi, Mark, Mankoff, David A.
Publicado en Phys Med Biol (2021)

Molecular Imaging Research in the Outcomes Era: Measuring Outcomes for Individualized Cancer Therapy

por Mankoff, David A., O’ Sullivan, Finbarr, Barlow, William E, Krohn, Kenneth A
Publicado 2007

Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient

por Mankoff, David A., Dunnwald, Lisa K., Partridge, Savannah C., Specht, Jennifer M.
Publicado 2009

Design considerations for using PET as a response measure in single- and multi-center clinical trials

por Doot, Robert K., Kurland, Brenda F., Kinahan, Paul E., Mankoff, David A.
Publicado 2011

Development of Companion Diagnostics

por Mankoff, David A., Edmonds, Christine E., Farwell, Michael D., Pryma, Daniel A.
Publicado en Semin Nucl Med (2016)

Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies

por Pantel, Austin R., Ackerman, Daniel, Lee, Seung-Cheol, Mankoff, David A., Gade, Terence P.
Publicado en J Nucl Med (2018)

Multicenter trials using FDG PET to predict chemotherapy response : Effects of differential measurement error and bias on power calculations for unselected and enrichment designs

por Kurland, Brenda F, Doot, Robert K, Linden, Hannah M, Mankoff, David A, Kinahan, Paul E
Publicado 2013

Radiopharmaceutical Chemistry and Drug Development—What’s Changed?

por Kunos, Charles A., Mankoff, David A., Schultz, Michael K., Graves, Stephen A., Pryma, Daniel A.
Publicado en Semin Radiat Oncol (2021)